Abstracts tagged "Ankylosing spondylitis (AS) and uveitis"

Abstract Number: 1705 • 2015 ACR/ARHP Annual Meeting
Acute Anterior Uveitis in Ankylosing Spondylitis: Association with Inflammatory Bowel Disease and Psoriasis Independent of HLA-B27
Ahmed Omar¹, Tristan Boyd², Ismail Sari¹, Arane Thavaneswaran³, Renise Ayearst¹, Robert D Inman⁴ and Nigil Haroon¹, ¹Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ²Rheumatology, University of California San Diego, La Jolla, CA, ³Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴Immunlogy and Institute of Medical Science, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada
Background/Purpose: Acute anterior uveitis (AAU) is the most common extra-articular manifestation in patients with ankylosing spondylitis (AS), developing in 20-30% of these patients during the…
Abstract Number: 1705 • 2013 ACR/ARHP Annual Meeting
Genetic Associations In Anterior Uveitis Implicate T-Cell Co-Stimulation and Other Immune Pathways
Philip Robinson¹, Dorith Claushuis², Paul Leo¹, Pamela Mukhopadhyay³, P. Wordsworth^4,5, Michael H. Weisman⁶, Walter P. Maksymowych⁷, Proton Rahman⁸, Robert Inman⁹, Alex Hewitt¹⁰, Tammy M. Martin¹¹, James T. Rosenbaum¹², Dennis Wakefield¹³, John D. Reveille¹⁴ and Matthew A. Brown¹⁵, ¹Human Genetics Group, University of Queensland Diamantina Insititute, Brisbane, Australia, ²Human Genetics Group, The University of Queensland Diamantina Institute, Brisbane, Australia, ³Human Genetics Group, The University of Queensland Diamantina Insititute, Brisbane, Australia, ⁴Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, ⁵Nuffield Orthopaedic Centre, Oxford, United Kingdom, ⁶Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ⁷Medicine, University of Alberta, Edmonton, AB, Canada, ⁸Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, ⁹Immunlogy and Institute of Medical Science, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada, ¹⁰Lions Eye Institute, University of Western Australia, Perth, Australia, ¹¹Ophthalmology/L467AD, Oregon Health & Science Univ, Portland, OR, ¹²Arthritis and Rheumatic diseases, Oregon Health and Science University, Portland, OR, ¹³Faculty of Medicine, University of New South Wales, Sydney, Australia, ¹⁴Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, ¹⁵University of Queensland Diamantina Institute, Brisbane, Australia
Background/Purpose: Anterior uveitis (AU) complicates a number of autoimmune diseases including ankylosing spondylitis (AS), Behcet’s disease and sarcoidosis. It is highly heritable and HLA-B27 is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].